IWM
RPRX icon

IMG Wealth Management’s Royalty Pharma RPRX Stock Holding History

IMG Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112 Buy
+2
New +$104 ﹤0.01% 574
2026
Q1 		– Sell
-258
Closed -$9.97K – 594
2025
Q4 		$9.97K Hold
258
– – 0.01% 316
2025
Q3 		$9.1K Hold
258
– – 0.01% 285
2025
Q2 		$9.3K Buy
+258
New +$8.55K 0.01% 274

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IMG Wealth Management's RPRX Position: Q2 2026 in Review

IMG Wealth Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 2 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: IMG Wealth Management previously reported a position in RPRX as recently as Q4 2025.

IMG Wealth Management first reported a position in RPRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $9.97K in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • IMG Wealth Management held 2 shares of Royalty Pharma worth $112 as of Q2 2026.
  • Royalty Pharma was a new IMG Wealth Management position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of IMG Wealth Management's portfolio in Q2 2026, its #574 holding.
  • IMG Wealth Management first reported a position in Royalty Pharma in Q2 2025 and has held it in 4 quarters since.
  • IMG Wealth Management's Royalty Pharma position peaked at $9.97K in Q4 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.